Production of the chemokine eotaxin-1 in osteoarthritis and its role in cartilage degradation

Journal of Cellular Biochemistry

Volumn 93, Issue 5, 2004, Pages 929-939

  Hsu, Yi Hsin ^a   Hsieh, Ming Shium ^b   Liang, Yu Chih ^c   Li, Chao Yi ^c   Sheu, Ming Thau ^c   Chou, Der Tsay ^b   Chen, Tzeng Fu ^c   Chen, Chien Ho ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chemokine; Chondrocyte; Eotaxin 1; Matrix metalloproteinase; Osteoarthritis

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; COLLAGENASE 3; EOTAXIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMELYSIN; BETA CHEMOKINE; CC CHEMOKINE RECEPTOR 3; CCL2 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; COLLAGENASE; EOSINOPHIL CHEMOTACTIC FACTOR; INTERLEUKIN 1; MMP13 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARTILAGE DEGENERATION; CHONDROSARCOMA; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ARTICULAR CARTILAGE; BLOOD; CARTILAGE CELL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY;

CARTILAGE, ARTICULAR; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CHONDROCYTES; COLLAGENASES; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; OSTEOARTHRITIS; RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 25444501689     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20239     Document Type: Article

References (41)

1. Alaaeddine N, Olee T, Hashimoto S, Creighton-Achermann L, Lotz M. 2001. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum 44:1633-1643.
2. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M. 1986. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039-1049.
3. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324.
4. Baggiolini M, Dewald B, Moser B. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97-179.
5. Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: An update. Annu Rev Immunol 15:675-705.
6. Banerjee S, Poole AR. 1992. Immunity to cartilage proteoglycans. J Rheumatol Suppl 33:36-39.
7. Borzi RM, Mazzetti I, Cattini L, Uguccioni M, Baggiolini M, Facchini A. 2000. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 43:1734-1741.
8. Campbell IK, Piccoli DS, Butler DM, Singleton DK, Hamilton JA. 1988. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator. Biochim Biophys Acta 967:183-194.
9. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182:1169-1174.
10. Goldring MB. 2000. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43:1916-1926.
11. Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM. 1988. Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 82:2026-2037.
12. Gonzalo JA, Jia GQ, Aguirre V, Friend D, Coyle AJ, Jenkins NA. 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 4:1-14.
13. Hornung D, Dohrn K, Sotlar K, Greb RR, Wallwiener D, Kiesel L, Taylor RN. 2000. Localization in tissue and secretion of eotaxin by cells from normal endometrium and endometriosis. J Clin Endocrinol Metab 85:2604-2608.
14. Hsieh MS, Ho HC, Chou DT, Pan S, Liang YC, Hsieh TY, Lan JL, Tsai SH. 2003. Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages. J Cell Biochem 89:791-799.
15. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ. 1994. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179:881-887.
16. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. 1996. Biochemical characterization of human collagenase-3. J Biol Chem 271:1544-1550.
17. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM. 1992. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 90:772-779.
18. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhverdi Z, Ghaffar O. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 159:4593-4601.
19. Lukacs NW, Hogaboam C, Campbell E, Kunkel SL. 1999. Chemokines: Function, regulation and alteration of inflammatory responses. Chem Immunol 72:102-120.
20. Martel-Pelletier J, Zafarullah M, Kodama S, Pelletier JP. 1991. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J Rheumatol Suppl 27:80-84.
21. Mattoli S, Stacey MA, Sun G, Bellini A, Marini M. 1997. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun 236:299-301.
22. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ. 1996. Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritis cartilage. J Clin Invest 97:761-768.
23. Muir H. 1995. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 17:1039-1048.
24. Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 107:35-44.
25. Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M. 2001. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 97:1920-1924.
26. Pelletier JP, Martel-Pelletier J, Abramson SB. 2001. Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum 44:1237-1247.
27. Peyron J. 1980. Inflammation of osteoarthritis (OA): Review of its role in clinical picture, disease progress, subsets and pathophysiology. Semin Arthritis Rheum 11(Suppl 1):115-116.
28. Poole AR. 1992. Immunology of cartilage. In: Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ, editors. Osteoarthritis: Diagnosis and medical/surgical management, 2nd edn. Philadelphia: WB Saunders. pp 155-189.
29. Radin EL, Burr DB, Caterson B, Fyhrie D, Brown TD, Boyd RD. 1991. Mechanical determinants of osteoarthrosis. Semin Arthritis Rheum 21:12-21.
30. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts: Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 268:5834-5839.
31. Rollins BJ. 1997. Chemokines. Blood 90:909-928.
32. Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P. 1995. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 181:1211-1216.
33. Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P. 1996. Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 92:8960-8964.
34. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. 1992. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 89:1512-1516.
35. Sozzani S, Locati M, Allavena P, Van Damme J, Mantovani A. 1996. Chemokines: A superfamily of chemotactic cytokines. Int J Clin Lab Res 26:69-82.
36. Taub DD, Oppenheim JJ. 1993. Review of the chemokine meeting: The Third International Symposium of Chemotactic Cytokines. Cytokine 5:175-179.
37. Westacott CI, Sharif M. 1996. Cytokines in osteoarthritis: Mediators or markers of joint destruction. Semin Arthritis Rheum 25:254-272.
38. Woessner JF, Jr. 1991. Matrix metalloproteinase and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154.
39. Ying S, Robinson DS, Meng Q, Rottman J, Kennedy R, Ringler DJ. 1997. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 27:3507-3516.
40. Yuan GH, Masuko-Hongo K, Sakata M, Tsuruha J-I, Onuma H, Nakamura H. 2001. The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum 44:1056-1070.
41. Yuan GH, Masuko-Hongo K, Kato T, Nishioka K. 2003. Immunologic intervention in the pathogenesis of osteoarthritis. Arthritis Rheum 48:602-611.